Literature DB >> 20553267

Pulmonary hypertension in sickle cell disease children under 10 years of age.

Raffaella Colombatti1, Nicola Maschietto, Elena Varotto, Alessandra Grison, Nicoletta Grazzina, Linda Meneghello, Simone Teso, Modesto Carli, Ornella Milanesi, Laura Sainati.   

Abstract

Despite the finding of elevated Tricuspid Regurgitant Velocity (TRV) in children below 5 years of age, the prevalence and evolution of Pulmonary Hypertension (PH) in young children with sickle cell disease (SCD) are unclear. In order to identify predictive factors of precocious PH development, SCD children > or =3 years old, at steady state, underwent annual echocardiography and Tissue Doppler Imaging (TDI). Patients receiving chronic transfusion were excluded. Thirty-seven of seventy-five patients were > or =3 years, with measurable TRV. In our young population (mean age 6.2 years) of mainly African, HbS/HbS patients, 8/37 (21.6%) had TRV > or =2.5 m/s, 8% being only 3 years old. Significant correlation was found between precocious TRV elevation and high platelet and reticulocyte counts and frequent acute chest syndromes (ACS). In multivariate analysis, ACS was the only variable predicting TRV > or =2.5 m/s. TDI of the 37 patients showed signs of diastolic dysfunction of the left ventricle. At follow-up all eight patients with high TRV displayed further increase and seven more developed TRV > or =2.5 m/s. PH seems to begin in children earlier than expected. Factors involved in its early onset might be different from the ones causing its development in older children or adults. African children might benefit from early screening and re-assessment once a year.

Entities:  

Mesh:

Year:  2010        PMID: 20553267     DOI: 10.1111/j.1365-2141.2010.08269.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  22 in total

1.  Vascular risk assessment in patients with sickle cell disease.

Authors:  Claudia R Morris
Journal:  Haematologica       Date:  2011-01       Impact factor: 9.941

2.  Changes in Bi-ventricular Function After Hematopoietic Stem Cell Transplant as Assessed by Speckle Tracking Echocardiography.

Authors:  Stuart Covi; Yaddanapudi Ravindranath; Ahmad Farooqi; Sureyya Savasan; Roland Chu; Sanjeev Aggarwal
Journal:  Pediatr Cardiol       Date:  2017-11-01       Impact factor: 1.655

3.  Longitudinal effect of disease-modifying therapy on tricuspid regurgitant velocity in children with sickle cell anemia.

Authors:  Parul Rai; Vijaya M Joshi; Jason F Goldberg; Amber M Yates; Victoria I Okhomina; Rhiannon Penkert; Kenneth I Ataga; Guolian Kang; Jane S Hankins
Journal:  Blood Adv       Date:  2021-01-12

Review 4.  Cardiomyopathy With Restrictive Physiology in Sickle Cell Disease.

Authors:  Omar Niss; Charles T Quinn; Adam Lane; Joshua Daily; Philip R Khoury; Nihal Bakeer; Thomas R Kimball; Jeffrey A Towbin; Punam Malik; Michael D Taylor
Journal:  JACC Cardiovasc Imaging       Date:  2016-02-17

5.  Echocardiographic markers of elevated pulmonary pressure and left ventricular diastolic dysfunction are associated with exercise intolerance in adults and adolescents with homozygous sickle cell anemia in the United States and United Kingdom.

Authors:  Vandana Sachdev; Gregory J Kato; J Simon R Gibbs; Robyn J Barst; Roberto F Machado; Mehdi Nouraie; Kathryn L Hassell; Jane A Little; Dean E Schraufnagel; Lakshmanan Krishnamurti; Enrico M Novelli; Reda E Girgis; Claudia R Morris; Erika Berman Rosenzweig; David B Badesch; Sophie Lanzkron; Oswaldo L Castro; James G Taylor; Hwaida Hannoush; Jonathan C Goldsmith; Mark T Gladwin; Victor R Gordeuk
Journal:  Circulation       Date:  2011-09-06       Impact factor: 29.690

6.  Unlocking the binding and reaction mechanism of hydroxyurea substrates as biological nitric oxide donors.

Authors:  Sai Lakshmana Vankayala; Jacqueline C Hargis; H Lee Woodcock
Journal:  J Chem Inf Model       Date:  2012-05-09       Impact factor: 4.956

7.  Hematopoietic stem-cell transplantation for sickle cell disease: current evidence and opinions.

Authors:  Shalini Shenoy
Journal:  Ther Adv Hematol       Date:  2013-10

8.  How does catalase release nitric oxide? A computational structure-activity relationship study.

Authors:  Sai Lakshmana Vankayala; Jacqueline C Hargis; H Lee Woodcock
Journal:  J Chem Inf Model       Date:  2013-10-28       Impact factor: 4.956

Review 9.  How I treat hypoxia in adults with hemoglobinopathies and hemolytic disorders.

Authors:  Evans M Machogu; Roberto F Machado
Journal:  Blood       Date:  2018-09-11       Impact factor: 22.113

10.  Doppler echocardiographic assessment of pulmonary artery pressure in children with sickle cell anaemia.

Authors:  Moriam Omolola Lamina; Barakat Adeola Animasahun; Ijeoma Nnena Akinwumi; Olisamedua Fidelis Njokanma
Journal:  Cardiovasc Diagn Ther       Date:  2019-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.